Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
In vitro mechanistic study in a 3D model system showing dose-dependent effects on colorectal cancer cells, but without clinical outcome data, in vivo validation, or comparison to standard therapies.
This is a mechanistic, in vitro comparative study of nanoparticle toxicity across cell types and conditions, offering structure–activity insights but lacking efficacy data, clinical endpoints, or in vivo validation necessary to guide therapeutic development.